🔎 Trials Near Me

Beranda › Leukemia Mielomonositik Juvenil › Pennsylvania › Philadelphia

Uji klinis Leukemia Mielomonositik Juvenil di Philadelphia, PA

4 studi untuk Leukemia Mielomonositik Juvenil mencari peserta di lokasi sekitar Philadelphia (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

Menerima pesertaFase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
1 Month – 21 Years · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT05849662

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

Menerima pesertaFase 1
  • Children's Hospital of Philadelphia, Philadelphia
Usia 1 hingga 18 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT06247787

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Menerima pesertaFase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi jauhnya
Hingga usia 22 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04726241

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Menerima peserta
  • Children's Hospital of Philadelphia, Philadelphia
Hingga usia 25 · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT03810196

Uji klinis Leukemia Mielomonositik Juvenil di kota lain

Studi lain di Philadelphia

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.